Autoimmune Diseases
Welcome,         Profile    Billing    Logout  
 293 Companies   491 Products   491 Products   198 Mechanisms of Action   26 Trials   7806 News 


«12...1415161718192021222324...156157»
  • ||||||||||  Trial initiation date:  Tissue Sodium in Autoimmune Disease (clinicaltrials.gov) -  May 10, 2017   
    P=N/A,  N=21, Not yet recruiting, 
    N=1000 --> 0 | Not yet recruiting --> Withdrawn Initiation date: Apr 2017 --> Dec 2017
  • ||||||||||  PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
    Trial completion, Trial primary completion date:  Protection Against Pneumococcal Infection in Children With T1DM (clinicaltrials.gov) -  May 9, 2017   
    P4,  N=50, Completed, 
    Not yet recruiting --> Recruiting Recruiting --> Completed | Trial primary completion date: Dec 2016 --> Apr 2016
  • ||||||||||  Trial completion, Phase classification, Trial primary completion date:  Low Level Laser Therapy for Autoimmune Thyroiditis (clinicaltrials.gov) -  May 5, 2017   
    P=N/A,  N=43, Completed, 
    Trial primary completion date: Jun 2014 --> Mar 2014 Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial primary completion date: Nov 2015 --> Mar 2016
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Physical Telerehabilitation in Veterans With Multiple Sclerosis (clinicaltrials.gov) -  May 5, 2017   
    P=N/A,  N=74, Completed, 
    Active, not recruiting --> Completed | Phase classification: P2/3 --> PN/A | Trial primary completion date: Nov 2015 --> Mar 2016 Recruiting --> Completed | N=170 --> 74 | Trial primary completion date: Jul 2015 --> Apr 2017
  • ||||||||||  H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
    Trial completion:  A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy (clinicaltrials.gov) -  May 4, 2017   
    P1/2,  N=10, Completed, 
    Recruiting --> Completed | Trial primary completion date: Oct 2016 --> Dec 2015 Active, not recruiting --> Completed
  • ||||||||||  Gardasil (quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine) / UniQuest
    Trial completion:  Immunogenicity of HPV Vaccine in Immunosuppressed Children (clinicaltrials.gov) -  May 4, 2017   
    P3,  N=55, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed, Enrollment change:  PBR28 PET and Inflammatory Arthritis (clinicaltrials.gov) -  May 4, 2017   
    P=N/A,  N=22, Active, not recruiting, 
    N=13 --> 20 | Trial primary completion date: Jan 2017 --> Jan 2018 Recruiting --> Active, not recruiting | N=12 --> 22
  • ||||||||||  Trial completion, Enrollment change:  The ANCA Vasculitis Questionnaire (AAV-PRO (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=280, Completed, 
    Initiation date: Feb 2017 --> Sep 2017 Active, not recruiting --> Completed | N=500 --> 280
  • ||||||||||  rivaroxaban / Generic mfg., warfarin / Generic mfg.
    Trial primary completion date:  TRAPS: Rivaroxaban in Thrombotic Antiphospholipid Syndrome (clinicaltrials.gov) -  May 3, 2017   
    P3,  N=536, Recruiting, 
    Active, not recruiting --> Completed | N=500 --> 280 Trial primary completion date: Dec 2018 --> Dec 2020
  • ||||||||||  Trial primary completion date:  PRISM: Pictorial Representation of Illness and Self Measure (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=220, Active, not recruiting, 
    Trial primary completion date: Dec 2018 --> Dec 2020 Trial primary completion date: Dec 2016 --> Jun 2017
  • ||||||||||  prednisone delayed-release tablet / Generic mfg.
    Phase classification, Enrollment change, Trial termination:  Delayed Release Prednisone in PMR (clinicaltrials.gov) -  May 3, 2017   
    P2,  N=8, Terminated, 
    Active, not recruiting --> Completed | Phase classification: P2 --> P1/2 | N=84 --> 64 Phase classification: P4 --> P2 | N=45 --> 8 | Recruiting --> Terminated; lack of study recruitment
  • ||||||||||  Trial completion, Phase classification, Trial primary completion date:  Walk for Rheumatoid Arthritis (WARA Study) (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=76, Completed, 
    Phase classification: P4 --> P2 | N=45 --> 8 | Recruiting --> Terminated; lack of study recruitment Recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Dec 2015 --> Mar 2016
  • ||||||||||  Trial primary completion date:  Brown Adipose Tissue in Type 1 Diabetes (clinicaltrials.gov) -  May 3, 2017   
    P=N/A,  N=12, Recruiting, 
    Recruiting --> Completed | Phase classification: P1/2 --> PN/A | Trial primary completion date: Dec 2015 --> Mar 2016 Trial primary completion date: Mar 2017 --> Sep 2017
  • ||||||||||  elcubragistat (Lu AG06466) / Lundbeck
    New P1 trial:  Central Pain Study for ABX-1431 (clinicaltrials.gov) -  May 3, 2017   
    P1,  N=32, Recruiting, 
  • ||||||||||  staphylococcal protein A (PRTX-100) / Protalex
    Phase classification, Trial primary completion date:  PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP (clinicaltrials.gov) -  Apr 28, 2017   
    P1b,  N=30, Recruiting, 
    Trial primary completion date: Feb 2017 --> Feb 2018 Phase classification: P1/2 --> P1b | Trial primary completion date: Jun 2017 --> Dec 2017
  • ||||||||||  Orencia (abatacept) / BMS
    Trial primary completion date:  Safety Study of Abatacept to Treat Rheumatoid Arthritis (B) (clinicaltrials.gov) -  Apr 27, 2017   
    P=N/A,  N=20000, Active, not recruiting, 
    Phase classification: P1/2 --> P1b | Trial primary completion date: Jun 2017 --> Dec 2017 Trial primary completion date: Mar 2017 --> Aug 2017
  • ||||||||||  Phase classification:  Project JAY THA Registration Study (clinicaltrials.gov) -  Apr 27, 2017   
    P=N/A,  N=100, Completed, 
    Active, not recruiting --> Completed Phase classification: P3 --> P=N/A
  • ||||||||||  azithromycin / Generic mfg.
    Enrollment change, Trial withdrawal, Trial primary completion date, Immunomodulating:  Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy (clinicaltrials.gov) -  Apr 27, 2017   
    P1/2,  N=0, Withdrawn, 
    Active, not recruiting --> Completed | Trial primary completion date: Dec 2018 --> Mar 2017 N=14 --> 0 | Enrolling by invitation --> Withdrawn | Trial primary completion date: Jul 2012 --> Nov 2014